Colja Laane

Chairman

Kees Recourt

Investment Director

2 past transactions

BioConnection

Secondary Market in 2022
BioConnection B.V., based in Oss, the Netherlands, specializes in biopharmaceutical development and manufacturing services for small and medium-sized biopharmaceutical companies. Established in 2005, the company offers a comprehensive range of services, including clinical fill and finish, formulation development, and the manufacturing of active biopharmaceutical ingredients. BioConnection provides access to both small-scale clinical batch production and large-scale commercial facilities, ensuring compliance with good manufacturing practices (GMP). The company leverages a robust network of skilled suppliers and partners, including Merck & Co., to deliver expertise in the complete clinical development process. This support is particularly beneficial for young biopharmaceutical firms that may lack the facilities or experience necessary for effective drug development. BioConnection serves various needs, from personalized medications to clinical trial materials, making it a versatile partner in the biopharmaceutical landscape.

Sirius Medical

Series A in 2020
Sirius Medical helps improve healthcare for cancer patients by developing medical devices that aid in surgical treatment. Their objective is to create intuitive and accurate gadgets that allow surgeons and radiologists to provide the finest treatment. Sirius Perception uses audio and visual feedback to provide real-time, directional advice for pinpointing tumors
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.